SO
NEOS

STRS Ohio’s Neos Therapeutics, Inc NEOS Stock Holding History

STRS Ohio’s Portfolio NEOS Stock Details NEOS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q2 		– Sell
-1,800
Closed -$19K – 2043
2016
Q1 		$19K Hold
1,800
– – ﹤0.01% 1826
2015
Q4 		$25K Hold
1,800
– – ﹤0.01% 1837
2015
Q3 		$37K Buy
+1,800
New +$39.7K ﹤0.01% 1785

Other funds holding NEOS

Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
SCM
Sio Capital Management New York $697M AUM 79.73% 1-Year Est. Return
DA
DSC Advisors Chicago, Illinois $11M AUM 5.88% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PI
Putnam Investments Boston, Massachusetts $75.7B AUM 34.45% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
WSA
Wall Street Associates Lajolla, California $151M AUM 30.3% 1-Year Est. Return

STRS Ohio's NEOS Position: Q2 2016 in Review

STRS Ohio sold out of Neos Therapeutics, Inc (NEOS) in Q2 2016, closing a stake of 1,800 shares — an estimated $19K sold.

STRS Ohio first reported a position in NEOS in Q3 2015 and held it in 3 quarters. The position peaked at $37K in Q3 2015. 46 funds tracked by Wall St. Rank hold NEOS as of Q2 2016.

  • STRS Ohio reported no remaining Neos Therapeutics, Inc position as of Q2 2016 after selling out during the quarter.
  • STRS Ohio sold 1,800 Neos Therapeutics, Inc shares in Q2 2016, an estimated $19K.
  • STRS Ohio first reported a position in Neos Therapeutics, Inc in Q3 2015 and held it in 3 quarters.
  • STRS Ohio's Neos Therapeutics, Inc position peaked at $37K in Q3 2015.
  • 46 funds tracked by Wall St. Rank held Neos Therapeutics, Inc as of Q2 2016.

Based on STRS Ohio's 13F filing for Q2 2016, filed 26 Jul 2016.